Moderna raises 2025 revenue forecast to $1.9 billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026 7:00 AM ESTExpects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings Call
Improves 2025 expected GAAP operating expenses by $200 million since 3Q25 Earnings Call
Increases 2025 projected year-end cash balance to approximately $8.1 billion (unaudited)
Reiterates plan to deliver up to 10% revenue growth and GAAP operating expense reductions in 2026
Anticipates potential first approvals of flu and flu/COVID combination products in 2026
Expects pivotal trial data readouts in oncology, rare disease and infectious disease in 2026
CAMBRIDGE,... More
